News
-
-
PRESS RELEASE
BASTIDE obtains an extended license to operate in Canada in the Respiratory Care segment / Sale of French stomatherapy subsidiary CICA PLUS
Groupe Bastide extends respiratory care license to British Columbia, Canada, while selling French subsidiary CICA PLUS specialized in stomatherapy. The company aims to boost organic growth in Canada and improve financials -
-
-
-
-
-
PRESS RELEASE
Highly dynamic organic growth in Q1 2024-25 at 9.0% : 10.9% growth in home healthcare services and rebound in the homecare business, up 6.0% / Disposal of Swiss commercial business finalized and 2024-2025 targets confirmed
Groupe Bastide reports solid organic growth of 9.0% in the first-quarter 2024-2025, with revenue reaching €133.8 million. Key focus on home healthcare services, international expansion, and strategic financial objectives -
-